Monoclonal antibodies for chronic migraine and medication overuse headache: A real-world study

BACKGROUND: Medication-overuse headache is highly prevalent in tertiary care centers. It may be a cause or consequence of the overuse of symptomatic medications for migraine attacks. OBJECTIVE: We aimed to compare the efficacy of anti-CGRP monoclonal antibodies (mAbs) added to conventional pharmacol...

Descripción completa

Detalles Bibliográficos
Autores principales: Krymchantowski, Abouch V., Jevoux, Carla, Krymchantowski, Ana Gabriela, Silva-Néto, Raimundo Pereira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10022428/
https://www.ncbi.nlm.nih.gov/pubmed/36937507
http://dx.doi.org/10.3389/fneur.2023.1129439

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10022428/
https://www.ncbi.nlm.nih.gov/pubmed/36937507
http://dx.doi.org/10.3389/fneur.2023.1129439

Ejemplares similares